Frontlight ResearchEarly access
Head and neck cancer trials in Russia
2 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1
- Where
- Kazan', Krasnoyarsk, Moscow, Saint Petersburg, Ufa
- Age
- 18 years and over
- People
- 64
- Run by
- Kidney Cancer Research Bureau
See details and how to joinNCT07292168 - Phase 2Not yet taking people in RussiaNeoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC
- Where
- Moscow
- Age
- 18 years to 75 years
- People
- 50
- Run by
- National Medical Research Radiological Centre of the Ministry of Health of Russia
See details and how to joinNCT07400094